Skip to main content
. 2006 Jan;44(1):236–238. doi: 10.1128/JCM.44.1.236-238.2006

TABLE 1.

Results of antibiogram analysis and genotyping of nine MRSA isolates of SCCmec type IV identified by PCR-RFLP analysis of the ccrB gene

Strain Origin Sample Antibiogramdresult
MLSTa(STe, allelic profilef) PFGE patterng
CEF CIP CLI ERY GEN OXA PEN TZP TET VAN
K-1 HA Sputum R S S R S R R R S S 72, 1-4-1-8-4-4-3 A
K-2 HA Wound I S S R S R R R S S 72, 1-4-1-8-4-4-3 A
K-3 HA Sputum S S S R S R R I S S 72, 1-4-1-8-4-4-3 A
K-4 HA Urine S S S R S R R I S S 72, 1-4-1-8-4-4-3 A
K-5 CA Woundb S S R S S R R R S S 375, 19-23-15-2-19-20-42 D
K-6 HA Ear discharge S S S R S R R R S S 72, 1-4-1-8-4-4-3 A
K-7 HA Nasal swab S S S R R R R R S S 72, 1-4-1-8-4-4-3 A1
K-8 CA Woundc S S S R S R R I S S 1, 1-1-1-1-1-1-1 B
K-9 HA Nasal swab S S S R I R R I S S 239, 2-3-1-1-4-4-3 C
a

MLST, multilocus sequence typing.

b

Cellulities.

c

Necrotizing fasciitis.

d

Antibiotic abbreviations: CEF, cephalothin; CIP, ciprofloxacin; CLI, clindamycin; ERY, erythromycin; GEN, gentamicin; OXA, oxacillin; PEN, penicillin; TZP, piperacillin-tazobactam; TET, tetracycline; VAN, vancomycin. R, resistant; S, susceptible; I, intermediate.

e

ST, sequence type.

f

Allelic profile: arcC aroE glpF gmk pta tpi yqiL.

g

According to criteria of Tenover et al. (19).